# Targeted oncology

Source: https://onco.cc/journals/targeted-oncology/  
OnCo record `targeted-oncology` (Journal). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Targeted Oncology is a Springer (Adis) journal about drugs aimed at specific molecular targets, including checkpoint inhibitors. It is read by oncologists and pharmacologists following new agents and pathways.

## Summary

Targeted Oncology, launched in January 2006 by Springer-Verlag France in Paris (NLM Catalog) and published today by Springer (Crossref), addresses physicians and scientists with a programme of articles on molecularly targeted pharmacotherapy in oncology. Its aims and scope page lists original research on molecularly targeted agents including immune checkpoint inhibitors, narrative reviews and shorter leading articles on established and emerging agents and pathways, current opinion pieces, Therapy in Practice guides, PRISMA-based systematic reviews, and Adis Drug Reviews of targeted drugs. Springer Nature Link lists the publishing model as hybrid. NLM records it as quarterly and indexed for MEDLINE.

## Fields

- Kind: Journal
- Last checked: 2026-09-10
- Also known as: Target Oncol; Targeted Oncology
- Publisher: Springer Nature (Adis)
- Scope: molecularly targeted cancer therapy
- Access: hybrid

## Sources

- Homepage: https://link.springer.com/journal/11523
- NLM Catalog: https://www.ncbi.nlm.nih.gov/nlmcatalog/101270595

## Connected records

- collections: [PubMed & Europe PMC](https://onco.cc/collections/pubmed-europepmc/)
- terms: [Immune checkpoint](https://onco.cc/terms/immune-checkpoint/), [Targeted therapy](https://onco.cc/terms/targeted-therapy-term/)
- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/)
- fronts: [Targeted Therapy](https://onco.cc/fronts/targeted-therapy/)

---
JSON: https://onco.cc/api/v1/entities/targeted-oncology.json